Venture financing: deals rise in clinical trials industry in H2
Exscientia had the highest value venture financing deal that took place in 2021, worth $225 million, based on available data.
By
Global
Latest in
Global
Aslan starts Phase IIb trial of atopic dermatitis IL-13 antibody
The trial is expected to enrol subjects across 100 sites in North America, Asia Pacific and Europe.
Biosimilars: top 10 pharma companies leading the way
The analysis is influenced by new biosimilars jobs, deals, patents, and mentions in company reports since January 2021.
By
Sorrento secures Brazil clearance to start Phase IIa long Covid trial
The trial will assess the safety and efficacy of up to three intravenous doses of COVI-MSC administered on alternate days.
Revealed: the pharma companies best equipped with AI
Many untapped AI opportunities in clinical trials, considering companies mainly focus on drug discovery and repurposing.
By
Internet of Things: Johnson & Johnson top innovator at tail end of 2021
Yet research and innovation in internet of things in the clinical trial operations sector has declined in the last year.
By
Resverlogix starts Phase IIb oral Covid-19 drug trial
The trial to assess the efficacy and safety of apabetalone will enrol 100 subjects at centres in Canada and Brazil.
Is precision medicine the future of obesity treatment?
Findings from a recent study could aid in the development of precision medicines for conditions such as obesity.
By